<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27368023</article-id>
      <article-id pub-id-type="pmc">4937937</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000004023</article-id>
      <article-id pub-id-type="art-access-id">04023</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>5200</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Devastating renal outcome caused by skin infection with methicillin-resistant <italic>Staphylococcus aureus</italic></article-title>
        <subtitle>A case report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liang</surname>
            <given-names>Jun-Hua</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff1">
            <sup>a</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fang</surname>
            <given-names>Yu-Wei</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>An-Hung</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref ref-type="aff" rid="aff3">
            <sup>c</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Ming Hsien</given-names>
          </name>
          <degrees>MD, MPH</degrees>
          <xref ref-type="aff" rid="aff2">
            <sup>b</sup>
          </xref>
          <xref>
            <sup>&#x2217;</sup>
          </xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Thajudeen.</surname>
            <given-names>Bijin</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>a</label>Division of Nephrology, Department of Medicine, Ten-Chen General Hospital, Yang-Mei</aff>
      <aff id="aff2"><label>b</label>Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital</aff>
      <aff id="aff3"><label>c</label>Ultrastructural and Molecular Pathology, Department of Pathology, Veterans General Hospital, Taipei, Taiwan.</aff>
      <author-notes id="cor1">
        <corresp><label>&#x2217;</label>Correspondence: Ming Hsien Tsai, Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, No. 95, Wen-Chang Rd, Shih-Lin Dist., Taipei 111, Taiwan (e-mail: <email>chaosmyth.tw@gmail.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>6</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>7</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>26</issue>
      <elocation-id>e4023</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>9</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>5</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0">http://creativecommons.org/licenses/by-nc-nd/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e4023.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) is an emerging pathogen that infects the skin and soft tissue. However, there are few reports of renal complications from MRSA involving immunoglobulin (Ig)A-dominated rapidly progressive glomerulonephritis (GN). Favorable renal outcomes from IgA GN are achieved by administering timely therapy. In the present study, we describe the case of a healthy young woman suffering from a cutaneous MRSA infection that initially presented with gross hematuria. Six months after eradicating the infection, severe impairment of renal function was noted because of intractable nausea and vomiting. Renal pathology revealed advanced IgA nephropathy with fibrocellular crescent formation. An aggressive treatment plan using immunosuppressants was not adopted because of her irreversible renal pathology, and she was therefore administered maintenance hemodialysis.</p>
        <p>This instructive case stresses the importance of being aware of the signs of IgA nephropathy post-MRSA infection, such as cutaneous lesions that are mostly painless and accompanied by hematuria and mild proteinuria. If the kidney cannot be salvaged, it will undergo irreversible damage with devastating consequences.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>hemodialysis</kwd>
        <kwd>immunoglobulin-A nephropathy</kwd>
        <kwd>methicillin-resistant <italic>Staphylococcus aureus</italic></kwd>
        <kwd>rapid progress glomerulonephritis</kwd>
        <kwd>renal impairment</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <label>1</label>
      <title>Introduction</title>
      <p>Historically, acute postinfectious glomerulonephritis (GN) is caused by <italic>Staphylococcus epidermidis</italic> and <italic>S. aureus</italic>, with typical findings of diffuse endocapillary proliferation and exudative GN on light microscopy, C3-dominant deposits with or without immunoglobulin (Ig)G codeposition on immunofluorescence, and subepithelial hump-shaped deposits on electron microscopy.<sup>[<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref>]</sup> A third pattern was recently described, termed superantigen-related GN or acute postmethicillin-resistant <italic>S. aureus</italic> (MRSA) GN, with the distinguishing feature of IgA- or IgA-codominant mesangial staining.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup></p>
      <p>Most of the causative pathogens of this disease are MRSAs, and favorable renal outcomes have been reported after timely administration of antibiotics and adequate immunosuppressant therapy.<sup>[<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref>]</sup> Regarding the emerging importance of MRSA-related IgA nephropathy, we present a patient who had an MRSA infection without awareness of early sign of GN, resulting in a devastating renal outcome with crescent formation from IgA-dominant postinfectious GN.</p>
    </sec>
    <sec>
      <label>2</label>
      <title>Case report</title>
      <p>A 22-year-old native Taiwanese woman was referred for the evaluation of rapidly developing advanced renal failure. Her medical history was unremarkable, and she had no personal or family history of the illness. A total of 6 months before referral, she had a community-acquired skin infection, initially in the left foot. Subsequently, she developed a skin abscess in the left posterolateral trunk with a pus culture that yielded MRSA. In addition to 2 weeks of antibiotic treatment with intravenous vancomycin (1&#x200A;g/8&#x200A;hour), an open surgical incision was performed. After her cutaneous infection resolved, painless gross hematuria occurred within 2 weeks. She believed that it was related to menstruation and did not receive further medical attention. Then, her serum creatinine (Cr) level was 1.2&#x200A;mg/dL (reference: 0.5&#x2013;1.3&#x200A;mg/dL).</p>
      <p>She was conscious on admission with a temperature of 35.8&#xB0;C, heart rate of 67&#x200A;beats/minute, and blood pressure of 156/89&#x200A;mm Hg. Examination of her heart, chest, and abdomen was unremarkable. The results of the laboratory tests of her serum were as follows: blood urea nitrogen, 60&#x200A;mg/dL (reference: 7&#x2013;25&#x200A;mg/dL); Cr, 6.8&#x200A;mg/dL; sodium, 137&#x200A;mEq/L (reference: 133&#x2013;145&#x200A;mEq/L); potassium, 4.5&#x200A;mEq/L (reference: 3.3&#x2013;5.1&#x200A;mEq/L); intact calcium, 4.58&#x200A;mg/dL (reference: 3.68&#x2013;5.6&#x200A;mg/dL); phosphate, 4.6&#x200A;mg/dL (reference: 2.5&#x2013;5&#x200A;mg/dL); uric acid, 5.6&#x200A;mg/dL; total protein, 4.6&#x200A;g/dL (reference: 6.0&#x2013;8.5&#x200A;g/dL); albumin, 3.3&#x200A;g/dL (reference: 3.5&#x2013;5.0&#x200A;g/dL); and hemoglobin, 9.1&#x200A;g/dL (reference: 12&#x2013;14&#x200A;g/dL). She had low serum levels of C3 (38.2&#x200A;mg/dL; reference: 79&#x2013;152&#x200A;mg/dL) and C4 (11.8&#x200A;mg/dL; reference: 16&#x2013;38&#x200A;mg/dL). Her immunoglobulin levels were as follows: IgG, 418&#x200A;mg/dL (reference: 751&#x2013;1560&#x200A;mg/dL); IgA, 135&#x200A;mg/dL (reference: 82&#x2013;453&#x200A;mg/dL); and IgM, 32.9&#x200A;mg/dL (reference: 46&#x2013;304&#x200A;mg/dL). Serological test results were all negative for antinuclear antibody, anti-DNA antibody, antineutrophil cytoplasmic antibody, antiglomerular basement membrane antibody, rheumatoid factor activity, hepatitis B surface antigen, and hepatitis C virus antibody. Urinalysis demonstrated a nephrotic range of proteinuria (4166&#x200A;mg/24&#x200A;hour, urine volume 1300&#x200A;mL/day), 16&#x2013;30&#x200A;cells/high-power field, and sterile pyuria. Renal ultrasound demonstrated normal bilateral kidney size (right kidney, 10&#x200A;cm; left kidney, 10.2&#x200A;cm) but with increased cortical echogenicity.</p>
      <p>A diagnostic renal biopsy was performed because of the unknown cause of her acute renal failure. Light microscopy revealed 9 glomeruli with 6 globally sclerotic glomeruli, 1 segmented sclerotic glomerulus, and 2 glomeruli with fibrocellular crescent formation. Moderate mesangial proliferation and matrix expansion was noted. An inflammatory infiltrate of mononuclear cells, diffuse interstitial fibrosis, and tubular atrophy were observed (Fig. <xref ref-type="fig" rid="F1">1</xref>). Immunofluorescence microscopy demonstrated diffuse global granular-predominant IgA staining (2<sup>+</sup>) with less intense C3 staining (1<sup>+</sup>) in the mesangium (Fig. <xref ref-type="fig" rid="F2">2</xref>). Electron microscopy revealed the effacement of podocyte foot processes, segmental expansion of the mesangial matrix, and electron-dense material in the mesangial area. There were no hump-shaped subepithelial deposits (Fig. <xref ref-type="fig" rid="F3">3</xref>). She was diagnosed with advanced IgA nephropathy with some crescent formation.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Glomerulus demonstrating (A) segmentally sclerotic change (periodic acid&#x2013;Schiff stain, &#xD7;600) and (B) mesangial proliferation with fibrocellular crescent formation (Jones&#x2019; silver stain, &#xD7;600).</p>
        </caption>
        <graphic xlink:href="medi-95-e4023-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Immunofluorescence staining for (A) IgA scored as 2+ and (B) C3 scored as 1+ granular deposition in the mesangium and glomerular capillary loops (original magnification &#xD7;600).</p>
        </caption>
        <graphic xlink:href="medi-95-e4023-g002"/>
      </fig>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Electron microscopy demonstrating (A) expansion of the mesangial matrix (original magnification &#xD7;4000) and (B) electron-dense deposits in the mesangium (original magnification &#xD7;20,000).</p>
        </caption>
        <graphic xlink:href="medi-95-e4023-g003"/>
      </fig>
      <p>According to these clinicopathological correlations, she was further diagnosed with crescentic IgA nephropathy secondary to MRSA infection. She had irreversible renal pathological change; therefore, plasma exchange and immunosuppressive therapies were not prescribed. Subsequently, she underwent maintenance dialysis.</p>
    </sec>
    <sec>
      <label>3</label>
      <title>Discussion</title>
      <p>In 1961, Powell<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> first identified staphylococcal infection as the cause of GN. Typically, postinfectious GN is dominated by IgG, detected using immunofluorescence, and by the presence of immune complex depositions with characteristic humps in the subepithelial areas of glomerular basement membranes. Recently, a new type of IgA-dominated postinfectious GN was described that is frequently associated with MRSA infections. The first cases of GN associated with MRSA infections were reported in 1995.<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> The main clinical characteristics are as follows: insidious onset of rapidly progressive renal failure, hematuria, and proteinuria<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> associated with different types of proliferative GN and varying degrees of crescent formation accompanied by codominant glomerular deposition of IgA.<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup> The cause of IgA post-MRSA GN remains unknown. One hypothesis implicates bacterial enterotoxins produced by MRSA as superantigens that lead to T cell activation, release of cytokines, and antibody production, such as IgA.<sup>[<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R7" ref-type="bibr">7</xref>]</sup> The development of monoclonal antibodies to <italic>S. aureus</italic> cell envelope antigen proved the existence of marked deposition found in the glomeruli.<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> Subsequently, this disease was detected in patients at an increased frequency than before the use of monoclonal antibodies.<sup>[<xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>&#x2013;<xref rid="R17" ref-type="bibr">17</xref>]</sup></p>
      <p>IgA-dominant MRSA-GN is often mistaken for idiopathic IgA nephropathy because of its similar immunofluorescence pattern. Findings favoring MRSA-GN over IgA nephropathy are as follows: hypocomplementemia, intercurrent staphylococcal infection, diffuse endocapillary hypercellularity with prominent neutrophil infiltration detected using light microscopy, and subepithelial humps detected using electron microscopy.<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> However, the characteristic subepithelial hump-shaped deposits are present in only 20% of patients.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> The hypotheses proposed to explain this feature are as follows: In contrast to IgG deposits that are resorbed, IgA deposited in poststaphylococcal GN persists even when the disease resolves. IgA-dominant MRSA-GN is a secondary form of IgA nephropathy.<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup> Our patient's characteristics were consistent with the diagnosis of IgA-dominant MRSA-GN, according to the findings described above. In our case, a subepithelial hump was absent, which may be due to the delayed finding of GN.</p>
      <p>Most patients with IgA-dominant MRSA-GN experience a fulminant course of acute renal failure, severe proteinuria, and variable hematuria. However, after early eradication of MRSA infection using an antibiotic, there have been reports of renal function recovering in patients.<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup> A separate report revealed the eradication of MRSA infection and restoration of renal function after additional steroid treatment.<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup> However, considering that infection causes this disease, aggressive steroid pulse therapy and immunosuppressant treatment for rapidly progressive crescentic GN is dangerous. Moreover, steroid therapy may induce a latent MRSA infection with potential for activation. Therefore, we suggest controlling the MRSA infection first with adequate antibiotics and then treating it according to the guideline for IgA nephropathy.<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup> Conservative therapy of renin-angiotensin system blockade with blood pressure control was initiated while the proteinuria was 0.5 to 1&#x200A;g/day. An add-on steroid therapy was administrated only when persistent proteinuria &gt;1&#x200A;g/day and glomerular filtrate rate &gt;50&#x200A;mL/minute per 1.73&#x200A;m<sup>2</sup> was detected after 3 to 6 months of optimized supportive care.</p>
      <p>Glomerular crescent formation is an uncommon occurrence in this new type of poststaphylococcal GN and complicates the clinical outcome. In total, 11 patients with this entity have been described in the literature; 9 were infected with MRSA, and 1 was infected with methicillin-sensitive staphylococcus aureus.<sup>[<xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R17" ref-type="bibr">17</xref>]</sup> The clinical characteristics of these patients included at least 1 with glomerular crescent formation on renal biopsy. In total, 6 patients received immunosuppressive therapy as well as antibiotics. All patients recovered partial renal function; however, 2 died because of infectious complications. The use of immunosuppressive therapy in this setting is unclear due to limited supporting evidence in literature. We suggest that immunosuppressant use should be considered when the patient's renal function deteriorates after well controlling the underlying MRSA infection. In our patient, although her skin infection resolved long before her admission, renal pathology was irreversible due to advanced fibrocellular crescent formation. Therefore, more aggressive treatment was not indicated, and she permanently lost her renal function at a young age.</p>
    </sec>
    <sec>
      <label>4</label>
      <title>Conclusion</title>
      <p>Because the incidence of MRSA infection is increasing, IgA crescentic GN due to MRSA may become a significant health issue. We emphasize the importance of being alert to the signs of GN when examining patients with prior MRSA infection because early intervention can rescue kidney function. We suggest conducting routine checks of patients&#x2019; urine using a dipstick post-MRSA infection to detect MRSA-related GN without delay.</p>
    </sec>
    <sec>
      <title>Acknowledgment</title>
      <p>We thank our patient for contributing clinical data to this report.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: Cr = creatinine, GN = glomerulonephritis, Ig = immunoglobulin, MRSA = methicillin-resistant <italic>Staphylococcus aureus</italic>.</p>
      </fn>
      <fn fn-type="other">
        <p>Ethical statement: Ethical approval was not required for this study as our study was focused on the retrospective observation of a patient's hospital course, which in no way affected his treatment. Informed consent was obtained from the patient regarding the reporting and publication of this case report.</p>
      </fn>
      <fn fn-type="conflict">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arze</surname><given-names>RS</given-names></name><name><surname>Rashid</surname><given-names>H</given-names></name><name><surname>Morley</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Shunt nephritis: report of two cases and review of the literature</article-title>. <source><italic>Clin Nephrol</italic></source>
<year>1983</year>; <volume>19</volume>:<fpage>48</fpage>&#x2013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">6831779</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>DE</given-names></name></person-group>
<article-title>Non-suppurative lesions in staphylococcal septicaemia</article-title>. <source><italic>J Pathol Bacteriol</italic></source>
<year>1961</year>; <volume>82</volume>:<fpage>141</fpage>&#x2013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">13737605</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyama</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen</article-title>. <source><italic>Kidney Int</italic></source>
<year>1995</year>; <volume>47</volume>:<fpage>207</fpage>&#x2013;<lpage>216</lpage>.<pub-id pub-id-type="pmid">7731148</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YR</given-names></name><name><surname>Wen</surname><given-names>YK</given-names></name></person-group>
<article-title>Favorable outcome of crescentic IgA nephropathy associated with methicillin-resistant <italic>Staphylococcus aureus</italic> infection</article-title>. <source><italic>Ren Fail</italic></source>
<year>2011</year>; <volume>33</volume>:<fpage>96</fpage>&#x2013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">21219214</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>AM</given-names></name><name><surname>Wall</surname><given-names>BM</given-names></name><name><surname>Cooke</surname><given-names>CR</given-names></name></person-group>
<article-title>Favorable outcome after aggressive treatment of infection in a diabetic patient with MRSA-related IgA nephropathy</article-title>. <source><italic>Am J Med Sci</italic></source>
<year>2009</year>; <volume>337</volume>:<fpage>221</fpage>&#x2013;<lpage>223</lpage>.<pub-id pub-id-type="pmid">19204555</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worawichawong</surname><given-names>S</given-names></name><name><surname>Girard</surname><given-names>L</given-names></name><name><surname>Trpkov</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infection</article-title>. <source><italic>Hum Pathol</italic></source>
<year>2011</year>; <volume>42</volume>:<fpage>279</fpage>&#x2013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">21111456</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoh</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Hirayama</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>A case of superantigen-related glomerulonephritis after methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) infection</article-title>. <source><italic>Clin Nephrol</italic></source>
<year>1997</year>; <volume>48</volume>:<fpage>311</fpage>&#x2013;<lpage>316</lpage>.<pub-id pub-id-type="pmid">9403216</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kai</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Hagiwara</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Post-MRSA infection glomerulonephritis with marked <italic>Staphylococcus aureus</italic> cell envelope antigen deposition in glomeruli</article-title>. <source><italic>J Nephrol</italic></source>
<year>2006</year>; <volume>19</volume>:<fpage>215</fpage>&#x2013;<lpage>219</lpage>.<pub-id pub-id-type="pmid">16736424</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagaba</surname><given-names>Y</given-names></name><name><surname>Hiki</surname><given-names>Y</given-names></name><name><surname>Aoyama</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Effective antibiotic treatment of methicillin-resistant <italic>Staphylococcus aureus</italic>-associated glomerulonephritis</article-title>. <source><italic>Nephron</italic></source>
<year>2002</year>; <volume>92</volume>:<fpage>297</fpage>&#x2013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">12218306</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasr</surname><given-names>SH</given-names></name><name><surname>Markowitz</surname><given-names>GS</given-names></name><name><surname>Whelan</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>IgA-dominant acute poststaphylococcal glomerulonephritis complicating diabetic nephropathy</article-title>. <source><italic>Hum Pathol</italic></source>
<year>2003</year>; <volume>34</volume>:<fpage>1235</fpage>&#x2013;<lpage>1241</lpage>.<pub-id pub-id-type="pmid">14691907</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handa</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Glomerulonephritis induced by methicillin-sensitive <italic>Staphylococcus aureus</italic> infection</article-title>. <source><italic>Clin Exp Nephrol</italic></source>
<year>2003</year>; <volume>7</volume>:<fpage>247</fpage>&#x2013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">14586723</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>JA</given-names></name><name><surname>Cook</surname><given-names>WJ</given-names></name></person-group>
<article-title>IgA deposits and acute glomerulonephritis in a patient with staphylococcal infection</article-title>. <source><italic>Am J Kidney Dis</italic></source>
<year>2006</year>; <volume>48</volume>:<fpage>851</fpage>&#x2013;<lpage>855</lpage>.<pub-id pub-id-type="pmid">17060008</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoskar</surname><given-names>AA</given-names></name><name><surname>Nadasdy</surname><given-names>G</given-names></name><name><surname>Plaza</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy</article-title>. <source><italic>Clin J Am Soc Nephrol</italic></source>
<year>2006</year>; <volume>1</volume>:<fpage>1179</fpage>&#x2013;<lpage>1186</lpage>.<pub-id pub-id-type="pmid">17699345</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Nogaki</surname><given-names>F</given-names></name><name><surname>Oida</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Glomerulonephritis induced by methicillin-resistant <italic>Staphylococcus aureus</italic> infection that progressed during puerperal period</article-title>. <source><italic>Clin Exp Nephrol</italic></source>
<year>2007</year>; <volume>11</volume>:<fpage>92</fpage>&#x2013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">17385005</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasr</surname><given-names>SH</given-names></name><name><surname>Share</surname><given-names>DS</given-names></name><name><surname>Vargas</surname><given-names>MT</given-names></name><etal/></person-group>
<article-title>Acute poststaphylococcal glomerulonephritis superimposed on diabetic glomerulosclerosis</article-title>. <source><italic>Kidney Int</italic></source>
<year>2007</year>; <volume>71</volume>:<fpage>1317</fpage>&#x2013;<lpage>1321</lpage>.<pub-id pub-id-type="pmid">17311069</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuyama</surname><given-names>S</given-names></name><name><surname>Wakui</surname><given-names>H</given-names></name><name><surname>Maki</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy</article-title>. <source><italic>Clin Nephrol</italic></source>
<year>2008</year>; <volume>70</volume>:<fpage>344</fpage>&#x2013;<lpage>347</lpage>.<pub-id pub-id-type="pmid">18826861</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeledon</surname><given-names>JI</given-names></name><name><surname>McKelvey</surname><given-names>RL</given-names></name><name><surname>Servilla</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>Glomerulonephritis causing acute renal failure during the course of bacterial infections. Histological varieties, potential pathogenetic pathways and treatment</article-title>. <source><italic>Int Urol Nephrol</italic></source>
<year>2008</year>; <volume>40</volume>:<fpage>461</fpage>&#x2013;<lpage>470</lpage>.<pub-id pub-id-type="pmid">18247152</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>M</given-names></name><name><surname>Racusen</surname><given-names>LC</given-names></name><name><surname>Bagnasco</surname><given-names>SM</given-names></name></person-group>
<article-title>IgA-dominant postinfectious glomerulonephritis: a report of 13 cases with common ultrastructural features</article-title>. <source><italic>Hum Pathol</italic></source>
<year>2008</year>; <volume>39</volume>:<fpage>1309</fpage>&#x2013;<lpage>1316</lpage>.<pub-id pub-id-type="pmid">18619648</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><comment>Chapter 10: Immunoglobulin A nephropathy. Kidney Int Suppl (2011)</comment>
<year>2012</year>; <volume>2</volume>:<fpage>209</fpage>&#x2013;<lpage>217</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
